Search results
8 mar 2023 · According to results from the 2020 study, the 5-year relative survival rate for vaginal melanoma was 19.2%. Fewer than 3% of vaginal cancers are carcinomas, which grow from deep inside the...
30 cze 2021 · The main treatment for both vulvar and vaginal melanoma is surgical excision of the tumor. Clinical experience in the last few decades has shown no significant differences in survival rates between radical excision and limited excisions with safety margins (Table 5), so limited resections are currently recommended [32,103].
25 paź 2022 · The number of involved nodes is also a strong predictor of survival for patients with VM: different survival rates at 24 months were shown for negative nodes (77%), 1–3 positive nodes (50%), and more than 3 positive nodes (0%) .
14 cze 2021 · While the mortality rate of cutaneous melanoma has dropped by 7% annually during the last 5 years, the prognosis of vulvar melanoma remains dismal: the 5-year overall survival rate is 47% compared with 92% for cutaneous melanoma.
4 lip 2024 · According to the Surveillance, Epidemiology, and End Results (SEER) Program from the National Cancer Institute, the 5-year relative survival rates for vaginal cancer between 2014 and 2020 were:...
8 gru 2023 · Abstract. Introduction: Primary vaginal malignant melanoma is a rare gynecological malignant tumor with high malignancy and poor prognosis. Because of its insidious incidence, it is generally diagnosed in the late stage, and the 5-year survival rate is only 5% to 25%.
27 cze 2024 · Conclusions: PVM is a disease with a poor prognosis; however, new treatment options are promising and have a great chance of significantly improving survival. The combination of the wide local excision of the primary lesion followed by adjuvant therapies results in the best outcomes in the treatment of PVM.
